EXEL - Exelixis Inc. patents

This listing is of recent patents (patent applications) which may be related to Exelixis Inc. according to a patent app search. In *most* cases, they are listed under Exelixis Inc. because the company is listed in the Agent field of the patent application. Note: Exelixis Inc. (EXEL) may have other listings under a different name, spelling or agent. If there is another company with a similar name, it's possible their patents could be inadvertantly included here. Notify us of any issues. Also, FreshPatents.com is not affiliated with Exelixis Inc., we're just tracking patents related to them as published publically by the USPTO. Full list of Stock Symbols and Company RSS Feeds

SUBSCRIBE to updates on this page: Exelixis Inc. patents RSS Feed (FREE)

E

EBAY
ECL
EGOV
EK
ELMG
ELX
ELY
EMIS
EMN
ENER
ENTG
ENTR
ENZ
ESIO
EW
EXAR
EXEL

Symbol	Company	Application #	Date	Title
EXEL	Exelixis	20120107827	20120503	Psmcs as modifiers of the rb pathway and methods of use
EXEL	Exelixis	20120070368	20120322	Methods of using c-met modulators
EXEL	Exelixis	20120064025	20120315	Quinazolinone modulators of nuclear receptors
EXEL	Exelixis	20120040985	20120216	Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
EXEL	Exelixis	20120035212	20120209	(l)-malate salt of n-(4-phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
EXEL	Exelixis	20120022065	20120126	C-met modulators and method of use
EXEL	Exelixis	20110301128	20111208	Pyrrole derivatives as pharmaceutical agents
EXEL	Exelixis	20110301188	20111208	Synergistic effects between sphingosine-1-phosphate receptor antagonists and antimicrotubule agents
EXEL	Exelixis	20110288076	20111124	Sphingosine-1-phosphate receptor antagonists
EXEL	Exelixis	20110263673	20111027	Atropisomers of (hydroxyalkyl) pyrrole derivatives
EXEL	Exelixis	20110263558	20111027	Azetidines as mek inhibitors for the treatment of proliferative diseases
EXEL	Exelixis	20110263544	20111027	1-phenylpyrrole derivatives
EXEL	Exelixis	20110237608	20110929	Pyridopyrimidinone inhibitors of pi3kalpha
EXEL	Exelixis	20110207712	20110825	Phosphatidylinositol 3-kinase inhibitors and methods of their use
EXEL	Exelixis	20110201599	20110818	Cdk modulators
EXEL	Exelixis	20110167505	20110707	Gfats as modifiers of the axin pathway and methods of use
EXEL	Exelixis	20110159508	20110630	Gfats as modifiers of the p53 pathway and methods of use
EXEL	Exelixis	20110144128	20110616	Heterocyclic carboxamide compounds as steroid nuclear receptors ligands
EXEL	Exelixis	20110135629	20110609	Eya2s as modifiers of the pten/akt pathway and methods of use
EXEL	Exelixis	20110123434	20110526	Combination therapies comprising quinoxaline inhibitors of p13k-alpha for use in the treatment of cancer
EXEL	Exelixis	20110111402	20110512	Kifs as modifiers of the rho pathway and methods of use
EXEL	Exelixis	20110077233	20110331	C-met modulators and method of use
EXEL	Exelixis	20110071145	20110324	Raf modulators and methods of use
EXEL	Exelixis	20110059066	20110310	Paks as modifiers of the chk pathway and methods of use
EXEL	Exelixis	20100087440	20100408	Phosphatidylinositol 3-kinase inhibitors and methods of their use
EXEL	Exelixis	20100075947	20100325	Methods of using pi3k and mek modulators

###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Exelixis Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Exelixis Inc. with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###